• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有显著抗肿瘤活性且对肌肉浸润性膀胱癌具有生物安全性的化疗药物二氢杨梅素。

Chemotherapeutic dihydromyricetin with remarkable anti-tumor activity and biosafety for muscle invasive bladder cancer.

作者信息

Guo Zicheng, Wang Wang, Hu Weikang, You Wenjie, Wang Zijian

机构信息

Department of Urology, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, China.

Hubei Key Laboratory of Urological Diseases, Department of Urology, Cancer Precision Diagnosis and Treatment and Translational Medicine Hubei Engineering Research Center, Zhongnan Hospital of Wuhan University, Wuhan, China.

出版信息

Front Pharmacol. 2025 Jul 18;16:1609354. doi: 10.3389/fphar.2025.1609354. eCollection 2025.

DOI:10.3389/fphar.2025.1609354
PMID:40756986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12314755/
Abstract

Plant-derived drugs (PDD) with remarkable anti-tumor activity and biosafety are highly desirable for clinical tumor chemotherapy. In this work, dihydromyricetin (DHM), a natural PDD extracted from ratten tea, was screened out to be a potential chemotherapeutic drug for muscle invasive bladder cancer (MIBC). The results of assays confirmed that DHM could effectively inhibit the proliferation, survival and migration of MIBC cells, and promote apoptosis ( < 0.05). M1 macrophage polarization was also observed after DHM chemotherapy. The hub genes in cell cycle and apoptosis signaling pathways were differential expressed, and the epithelial-mesenchymal transition (EMT) in MIBC cells was also reversed by DHM treatment. The effectiveness and biosafety evaluations of DHM chemotherapy were performed using a xenograft bearing mice model. The results revealed that DHM intravenous chemotherapy with a dose of 20 mg/kg for 7 times could significantly suppress the tumorigenesis of MIBC ( < 0.05), while triggered no obvious drug side effects. In conclusion, this work provided a PPD with remarkable and anti-tumor activity and biosafety, which could serve as a promising alternative for the application of MIBC chemotherapy.

摘要

具有显著抗肿瘤活性和生物安全性的植物源药物(PDD)是临床肿瘤化疗的理想选择。在这项研究中,从藤茶中提取的天然PDD二氢杨梅素(DHM)被筛选为肌肉浸润性膀胱癌(MIBC)的潜在化疗药物。实验结果证实,DHM可有效抑制MIBC细胞的增殖、存活和迁移,并促进细胞凋亡(<0.05)。DHM化疗后还观察到M1巨噬细胞极化。细胞周期和凋亡信号通路中的枢纽基因差异表达,DHM处理也逆转了MIBC细胞中的上皮-间质转化(EMT)。使用荷瘤小鼠模型对DHM化疗的有效性和生物安全性进行了评估。结果显示,20mg/kg剂量的DHM静脉化疗7次可显著抑制MIBC的肿瘤发生(<0.05),且未引发明显的药物副作用。总之,这项研究提供了一种具有显著生物安全性和抗肿瘤活性的PDD,可为MIBC化疗应用提供有前景的替代方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b79/12314755/1f6e8b0bb532/fphar-16-1609354-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b79/12314755/009802e82bcf/fphar-16-1609354-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b79/12314755/23dc4e7d1ce4/fphar-16-1609354-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b79/12314755/b83414bea5e9/fphar-16-1609354-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b79/12314755/b9fb78103f1b/fphar-16-1609354-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b79/12314755/3033bdcd4c92/fphar-16-1609354-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b79/12314755/1f6e8b0bb532/fphar-16-1609354-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b79/12314755/009802e82bcf/fphar-16-1609354-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b79/12314755/23dc4e7d1ce4/fphar-16-1609354-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b79/12314755/b83414bea5e9/fphar-16-1609354-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b79/12314755/b9fb78103f1b/fphar-16-1609354-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b79/12314755/3033bdcd4c92/fphar-16-1609354-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b79/12314755/1f6e8b0bb532/fphar-16-1609354-g006.jpg

相似文献

1
Chemotherapeutic dihydromyricetin with remarkable anti-tumor activity and biosafety for muscle invasive bladder cancer.具有显著抗肿瘤活性且对肌肉浸润性膀胱癌具有生物安全性的化疗药物二氢杨梅素。
Front Pharmacol. 2025 Jul 18;16:1609354. doi: 10.3389/fphar.2025.1609354. eCollection 2025.
2
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
5
Unveiling the molecular mechanisms of human platelet lysate in enhancing endometrial receptivity.揭示人血小板裂解物增强子宫内膜容受性的分子机制。
Hum Reprod. 2025 Jul 15. doi: 10.1093/humrep/deaf118.
6
The quantity, quality and findings of network meta-analyses evaluating the effectiveness of GLP-1 RAs for weight loss: a scoping review.评估胰高血糖素样肽-1受体激动剂(GLP-1 RAs)减肥效果的网状Meta分析的数量、质量及结果:一项范围综述
Health Technol Assess. 2025 Jun 25:1-73. doi: 10.3310/SKHT8119.
7
Construction of a column-line graphical model of poor outcome of neoadjuvant regimens for muscle-invasive bladder cancer based on NLR, dNLR and SII indicators.基于中性粒细胞与淋巴细胞比值(NLR)、动态中性粒细胞与淋巴细胞比值(dNLR)和全身免疫炎症指标(SII)构建肌层浸润性膀胱癌新辅助治疗方案不良预后的列线图模型
World J Surg Oncol. 2025 Jul 10;23(1):274. doi: 10.1186/s12957-025-03903-1.
8
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
9
Dihydromyricetin confers cerebroprotection against subarachnoid hemorrhage via the Nrf2-dependent Prx2 signaling cascade.二氢杨梅素通过 Nrf2 依赖的 Prx2 信号级联发挥对蛛网膜下腔出血的脑保护作用。
Phytomedicine. 2023 Oct;119:154997. doi: 10.1016/j.phymed.2023.154997. Epub 2023 Jul 26.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.

本文引用的文献

1
FPCAM: A Weighted Dictionary-Driven Model for Single-Cell Annotation in Pulmonary Fibrosis.FPCAM:一种用于肺纤维化单细胞注释的加权字典驱动模型。
Biology (Basel). 2025 Apr 26;14(5):479. doi: 10.3390/biology14050479.
2
Opportunities and challenges with artificial intelligence in allergy and immunology: a bibliometric study.人工智能在过敏与免疫学领域的机遇与挑战:一项文献计量学研究
Front Med (Lausanne). 2025 Apr 9;12:1523902. doi: 10.3389/fmed.2025.1523902. eCollection 2025.
3
Biomolecular Microneedle Initiates FeO/MXene Heterojunction-Mediated Nanozyme-Like Reactions and Bacterial Ferroptosis to Repair Diabetic Wounds.
生物分子微针引发FeO/MXene异质结介导的类纳米酶反应和细菌铁死亡以修复糖尿病伤口。
Adv Sci (Weinh). 2025 Mar;12(11):e2417314. doi: 10.1002/advs.202417314. Epub 2025 Jan 23.
4
Dihydromyricetin: an emerging compound with comprehensive effects on multiple systems.二氢杨梅素:一种对多个系统具有综合作用的新兴化合物。
Front Pharmacol. 2025 Jan 3;15:1488003. doi: 10.3389/fphar.2024.1488003. eCollection 2024.
5
Safety and efficacy of the MP1000 surgical system in robot-assisted radical cystectomy: A prospective study.MP1000手术系统在机器人辅助根治性膀胱切除术中的安全性和有效性:一项前瞻性研究。
Bladder (San Franc). 2024 Nov 6;11(3):e21200013. doi: 10.14440/bladder.2024.0026. eCollection 2024.
6
Perioperative, functional, and oncological outcomes of Da Vinci vs. Hugo RAS for robot‑assisted radical prostatectomy: evidence based on controlled studies.达芬奇机器人与 Hugo RAS 机器人辅助根治性前列腺切除术的围手术期、功能和肿瘤学结果:基于对照研究的证据。
J Robot Surg. 2024 Oct 24;18(1):379. doi: 10.1007/s11701-024-02146-8.
7
Bioprinted research models of urological malignancy.泌尿外科恶性肿瘤的生物打印研究模型
Exploration (Beijing). 2024 Feb 20;4(4):20230126. doi: 10.1002/EXP.20230126. eCollection 2024 Aug.
8
Establishing an Intravesical Doublet Chemotherapy Clinic for Nonmuscle-Invasive Bladder Cancer Patients.为非肌肉浸润性膀胱癌患者设立膀胱内双联化疗诊所。
Urol Pract. 2024 Jul;11(4):613-623. doi: 10.1097/UPJ.0000000000000576. Epub 2024 May 24.
9
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024.NCCN 指南®洞察:膀胱癌,第 3.2024 版。
J Natl Compr Canc Netw. 2024 May;22(4):216-225. doi: 10.6004/jnccn.2024.0024.
10
Engineered exosomes and composite biomaterials for tissue regeneration.用于组织再生的工程化外泌体和复合生物材料。
Theranostics. 2024 Mar 3;14(5):2099-2126. doi: 10.7150/thno.93088. eCollection 2024.